3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Recurrence
1
Peritoneal Neoplasms
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Ovarian Diseases
1
Neoplasms, Glandular and Epithelial
1
Neoplasms
1
Immunologic Deficiency Syndromes
1
Glioblastoma
1
Genital Neoplasms, Female
1
Fallopian Tube Neoplasms
1
Epstein-Barr Virus Infections
1
Cytomegalovirus Infections
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma in Situ
1
Adenoviridae Infections
1
Abdominal Neoplasms
1
Interventions
Capecitabine
41
Oxaliplatin
39
Fluorouracil
29
Leucovorin
23
Radiotherapy
21
Cetuximab
14
Bevacizumab
14
Irinotecan
13
Nivolumab
12
Magnetic Resonance Spectroscopy
11
Specimen Handling
9
Surgical Procedures, Operative
8
Folfox protocol
8
Drug Therapy
8
pembrolizumab
7
Radiotherapy, Intensity-Modulated
7
Chemoradiotherapy
7
Biopsy
7
trifluridine tipiracil drug combination
6
Radiation
6
tislelizumab
5
sintilimab
5
regorafenib
5
dehydroftorafur
5
X-Rays
5
Surveys and Questionnaires
5
Sigmoidoscopy
5
Endoscopy
5
Consolidation Chemotherapy
5
spartalizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
Cell Count
×
1 year
×
Clear all
No trials found.